← All Medifast INC filings

Medifast INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
MED
Medifast INC
10-K: Medifast Reports Fiscal Year 2024 Results Amidst Transformation
Medifast navigates a challenging year with a focus on adapting to the evolving weight-loss market and integrating GLP-1 solutions.
NYSE
MED
Medifast INC
10-K: Medifast, Inc. Reports Full Year 2023 Results, Announces Strategic Shift Towards Medically Supported Weight Loss
Medifast, Inc. reports a decrease in revenue and earnings for 2023, while outlining a strategic shift towards medically supported weight loss and other growth initiatives.